Nat Peckett

Nat Peckett

Auto-generated profile, based on publicly available information

Nat Peckett

Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in Nature
Verified
Journal Article
Open access
PDF file
PCPatrizia Cammareri
Patrizia Cammareri
MRMichela Raponi
Michela Raponi
YHYourae Hong
Yourae Hong
CBCaroline V. Billard
Caroline V. Billard
NPNat Peckett
Nat Peckett
KMKevin B. Myant
Kevin B. Myant
Cancer cell plasticity enables the acquisition of new phenotypic features and is implicated as a major driver of metastatic progression1,2. Metastasis occurs mostly in the absence of additional genetic alterations3–5, which suggests that epigenetic mechanisms are important6. However, they remain poorly defined. Here we identify the chromatin-remodelling enzyme ATRX as a key regulator of colonic lineage fidelity and metastasis in colorectal cancer. Atrx loss promotes tumour invasion and metastasis, concomitant with a loss of colonic epithelial identity and the emergence of highly plastic mesenchymal and squamous-like cell states. Combined analysis of chromatin accessibility and enhancer mapping identified impairment of activity of the colonic lineage-specifying transcription factor HNF4A as a key mediator of these observed phenotypes. We identify squamous-like cells in human patient samples and a squamous-like expression signature that correlates with aggressive disease and poor patient prognosis. Collectively, our study defines the epigenetic maintenance of colonic epithelial identity by ATRX and HNF4A as suppressors of lineage plasticity and metastasis in colorectal cancer.